Educational guide
Cyclo(-RGDfK) Peptide, CAS 161552-03-0 | Integrin Inhibitor
Cyclo(-RGDfK), CAS 161552-03-0 US$1,096.75 Excluding tax and shipping fees In stock Description About Cyclo(-RGDfK), CAS 161552-03-0 Cyclo(-RGDfK), CAS 161552-03-0 is a potent/selective inhibitor of integrin αvβ3 binding for cancer-targeting research. The Cycl
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Cyclo(-RGDfK), CAS 161552-03-0
US$1,096.75
Excluding tax and shipping fees
In stock
Description
About Cyclo(-RGDfK), CAS 161552-03-0
Cyclo(-RGDfK), CAS 161552-03-0 is a potent/selective inhibitor of integrin αvβ3 binding for cancer-targeting research. The Cyclo(-RGDfK), CAS 161552-03-0 Peptide, RGDfK (cyclic peptide, head-to-tail) from JPT is produced under strict quality control and quality management.
Cyclo(-RGDfK), CAS 161552-03-0- Specifications
Peptide sequence: RGDfK (cyclic peptide, head-to-tail)
Amount: 1 mg
Purity: > 90% (HPLC/MS)
Counterion: TFA
Delivery Format: Freeze-dried in plastic vial
Application(s): Cancer research
Condition(s)/Topic(s): Cancer
Standard Delivery Time: approx. 3 weeks
RGD Cancer Peptides from JPT
Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.
Benefits of JPT’s RGD Cancer Peptides
Each peptide quality controlled and guaranteed for identity and purity
CoA and HPLC-MS data available
High batch-to-batch consistency
Synthesis protocols designed to avoid toxic contaminants and side products
Provision of freeze dried aliquots for enhanced stability
Proven track record for applications in clinical studies
References
References for Cyclo(-RGDfK), CAS 161552-03-0
ReferencesRead References with Peptides made by JPT
Documentation
Documentation for Cyclo(-RGDfK), CAS 161552-03-0
GRGD-acid - CAS 97461-81-9.pdf
Properties
Properties of Cyclo(-RGDfK), CAS 161552-03-0
1 mg
Cancer peptides
Cancer
Freeze-dried in plastic vial
Artificial
Other
>90% (HPLC-MS)
No
Further Information to Cyclo(-RGDfK), CAS 161552-03-0
Values
RGDfK (cyclic peptide, head-to-tail)
cyclized RGD cancer peptide
Related Products
Related Products
GRGD-acid, CAS 97461-81-9
US$177.67
GRGDSP, CAS 91037-75-1
US$282.50
RGD-4C, CAS 332179-76-7
[Pyr 1]-Apelin-13, CAS 217082-60-5
US$186.52